share_log

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC

Nephros將於2024年12月11日在紐約參加Benchmark公司年度Discovery一對一投資者會議
GlobeNewswire ·  2024/12/04 22:00

SOUTH ORANGE, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will be participating in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference. The event is scheduled for Wednesday, December 11, 2024, at the New York Athletic Club in New York City.

新澤西州南橘鎮,2024年12月04日(環球新聞社)--納斯達克股票代碼爲NEPH的nephros公司,是一家領先的水技術公司,爲醫療和商業市場提供過濾解決方案,今天宣佈將參加Benchmark公司第13屆全球投資者會議。該活動定於2024年12月11日星期三在紐約市紐約運動俱樂部舉行。

Robert Banks, CEO and Judy Krandel, CFO of Nephros, Inc. will be hosting one-on-one and group investor meetings. If you would like to schedule a 1x1 investor meeting please make sure you are registered here:

nephros公司的首席執行官Robert Banks和首席財務官Judy Krandel將舉辦一對一和團體投資者會議。如果您想安排一次投資者會議,請確保在這裏註冊:

The conference offers emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Nephros will be participating in one-on-one meetings with investors and analysts throughout the day.

該會議爲新興增長和充滿活力的上市公司提供機會,讓機構和個人投資者以獨特的一對一形式與Nephros進行會議,與投資者和分析師進行全天的一對一會議。

About The Benchmark Company

關於基準公司

The Benchmark Company is an institutionally focused, research driven, sales trading and investment banking firm. We were founded in 1988 and are headquartered in New York City. Our focus is on fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful research, and developing institutional sponsorship by leveraging the firm's sales, trading, and equity research capabilities. .

Benchmark公司是一家以機構爲重點、以研究爲驅動、銷售交易和投資銀行業務爲主的公司。我們成立於1988年,總部位於紐約市。我們專注於通過籌集資本、提供戰略諮詢服務、生成富有見地的研究,並通過利用公司的銷售、交易和股票研究能力來發展機構贊助,從而促進客戶的長期成功。

About Nephros
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.

關於nephros
Nephros致力於通過領先的、易獲得的科技來改善人類與水的關係。我們提供創新的水過濾產品和服務,以及水質教育,作爲綜合水安全方法的一部分。Nephros的產品滿足醫療保健和商業市場客戶的需求,爲水管理提供預防性和緊急解決方案。

For more information about Nephros, please visit us at nephros.com.

有關Nephros的更多信息,請訪問我們的網站nephros.com。

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

投資者關係聯繫人:
柿子史密斯,總裁
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com

Robert Banks, CEO
Nephros, Inc.
(201) 343-5202 x110
robert.banks@nephros.com

羅伯特銀行首席執行官
nephros公司
(201) 343-5202 x110
robert.banks@nephros.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論